ProQR Therapeutics N.V. Ordinary Shares
Market Cap
150M
Short interest (May 15)
0.8%
Net Short (Jun 03 ): 0.0%
Borrow Fee
0.48%
↓ 14.2%
Available Shares
2M
↓ 10.3%
Price Chart
Company Overview
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.